Pyxis Oncology
PYXS • NASDAQ
Pyxis Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas Civik, with a market cap of $82.3M.
Market Cap$82.3M
Employees51.0
CEOThomas Civik
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Pyxis Oncology FAQ
Common questions about Pyxis Oncology
Pyxis Oncology is scheduled to report earnings for Q1 2026 on May 14, 2026.
Pyxis Oncology has approximately 51 employees.